Vinay Prasad’s second exit from FDA leadership after less than a year in his positions didn’t come as a major surprise. But with his two positions now left to fill — as the director of CBER …
CMS innovation center to expand team focused on drug prices
To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff. “We are on



